Smoking, Urban Housing and Work-Aggravated Asthma are Associated with Asthma Severity in a Cross-Sectional Observational Study.

ASSESS allergy asthma environment severity

Journal

Journal of asthma and allergy
ISSN: 1178-6965
Titre abrégé: J Asthma Allergy
Pays: New Zealand
ID NLM: 101543450

Informations de publication

Date de publication:
2024
Historique:
received: 06 06 2023
accepted: 02 12 2023
medline: 6 2 2024
pubmed: 6 2 2024
entrez: 6 2 2024
Statut: epublish

Résumé

Severe asthma affects 5 to 10% of asthmatics and accounts for a large part of asthma-related morbidity and costs. The determinants of asthma severity are poorly understood. We tested the hypothesis that asthma severity was associated with 1) atopy and allergy and 2) markers associated with environmental exposure. Data from the FASE-CPHG study, a cross-sectional, observational, multicenter investigation, were analyzed to identify markers associated with asthma severity. Asthma severity was gauged using the ASSESS score, encompassing symptom control, exacerbations, FEV1 and therapeutic load. Bivariate and multivariate analyses were used to identify patient characteristics associated with the ASSESS score. The analysis involved 948 patients, with 592 women, of which 447 patients (47%) had severe asthma. Among these, 491 patients (52%) had at least one positive aeroallergen skin prick test and 525 (55%) had at least one allergic disease among atopic dermatitis, chronic rhinitis and food allergy. The mean±SD ASSESS score was 11.2±3.4. Characteristics associated with a higher ASSESS score were female sex, secondary or lower education, unemployed occupational status, smoking, work-aggravated asthma and urban housing. There was no association between the ASSESS score and allergic diseases, aeroallergen-specific skin prick tests and IgEs, or blood eosinophil counts. While atopy and allergy were frequent among asthmatics, neither was associated with asthma severity. Modifiable environmental factors such as smoking, urban housing and work-aggravated asthma were independently associated with asthma severity.

Identifiants

pubmed: 38318088
doi: 10.2147/JAA.S424546
pii: 424546
pmc: PMC10840413
doi:

Types de publication

Journal Article

Langues

eng

Pagination

69-79

Informations de copyright

© 2024 Chevereau-Choquet et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest in this work.

Auteurs

Marie Chevereau-Choquet (M)

Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.

Benjamin Thoreau (B)

Service de Médecine Interne, National Referral Center for Rare Systemic Autoimmune Diseases, AP-HP, Hôpital Cochin, Paris, France.
Inserm U1016, CNRS UMR8104, Université Paris Cité, Institut Cochin, Paris, France.

Camille Taillé (C)

Service de Pneumologie A, AP-HP Nord, Hôpital Bichat Claude Bernard, Paris, France.
Inserm U1152, Université Paris Cité, Paris, France.

Sylvain Marchand-Adam (S)

Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.
CEPR, Inserm UMR1100, Université de Tours, Tours, France.

Hugues Morel (H)

Service de Pneumologie, CHR d'Orléans, Orléans, France.

Laurent Plantier (L)

Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.
CEPR, Inserm UMR1100, Université de Tours, Tours, France.

Laurent Portel (L)

Service de Pneumologie, Centre Hospitalier Robert Boulin, Libourne, France.

Classifications MeSH